Article and Video CATEGORIES

Cancer Journey

Search By

Induction Chemotherapy Followed by Chemo/Radiation for Stage III NSCLC
Author
GRACE Videos and Articles
GRACE Cancer Video Library - Lung

GCVL_LU-E10b_Induction_Chemo_Radiation_Stage_III_NSCLC

 

Dr. Mark Socinski, University of Pittsburgh Medical Center, discusses the benefits of giving two additional cycles of chemotherapy in combination with radiotherapy for stage III NSCLC.

 

Transcript

One of the areas of controversy is with regard to induction chemotherapy, followed by chemoradiotherapy in stage III disease. I mentioned before that systemic micrometastatic disease is a huge problem in these patients, and one has to give adequate, effective chemotherapy in this setting. We typically give chemotherapy with radiation, but radiotherapy strategies typically last six to seven weeks, and therefore, that would really account for essentially two cycles of chemotherapy. Now, in stage II or III when we are giving adjuvant therapy, or in the metastatic stage IV setting, our current standard is to give four cycles of chemotherapy in that setting, maybe sometimes six in the stage IV setting, so I’ve always wondered why would we just give two cycles concurrent with chemoradiotherapy in the stage III setting?

However, I will tell you that all the level one evidence does not routinely support the use of more chemotherapy, other than during the radiotherapy. Obviously, it could be given before, as so-called induction, or it could be given after chemoradiation, so-called consolidation therapy. Many investigators have pursued giving two cycles prior to initiation of chemoradiation — that’s a strategy that I like personally, and frequently do in my practice. I don’t have level one evidence to suggest that it’s a strategy that has, in clinical trials, which in my opinion have been limited and relatively small in number, so relatively underpowered in this setting — but the advantage of induction therapy is, often patients are symptomatic, the response rates tend to be in the 40-60%, depending upon which study you look at — a response makes the patient feel better because their symptoms may get better, but the other thing it does is that it may allow a smaller field of radiation, if you believe that it’s okay to treat the volume of cancer that is present after chemotherapy, which is what we do at our particular center. So it may allow a smaller field of radiation be using induction therapy, that may then reduce the toxicities you may see during chemoradiation.

Again, this strategy has not been proven at the phase III level one evidence. However, it’s very commonly used and I will also note that it’s very common for a practicing oncologist to recommend two cycles of consolidation chemotherapy if the initial treatment is concurrent chemoradiotherapy. So rather than give chemotherapy before, it’s given afterwards. Again, not a proven strategy at the phase III level one evidence point of view, however, many of our major clinical trials done in cooperative groups allow two cycles as consolidation therapy, which is typically what is commonly done in practice.

My personal bias is that you should think about giving four cycles in this particular setting. I think two cycles are inadequate to control micrometastatic disease, particularly if during radiation, the chemotherapy strategy that is pursued is low-dose weekly approaches, which may not be the optimal way to control systemic disease.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi Bluebird,  Welcome to GRACE.  I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had. 

 

A CT would be...

Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...

Hi and welcome to GRACE.  I'm sorry to know you are entering a new stage.  I'm not about to comment just now but wanted to let you know I see your...

Edit to say, we can't give advice but we can comment with views and facts.  :)

 

My first thought is to ask if she has been seen at a large...

Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...

Thank you, Janine, for answering so rapidly. I am aware that my nodules are small, but they scare me all the same. Your words that nodule measurements may vary somewhat when...

Hi Barbro,  I'm sorry you're worrying about this, and don't feel like you can discuss this with your doctor.  Speak to your doctor about this.  Let them know your worries and...

Recent Comments

JOIN THE CONVERSATION
what a disgrace doctor is
By ROSHAN_bhatia on
Hi Bluebird,  Welcome to…
By JanineT GRACE … on
Hi Barbro,  I'm sorry you're…
By JanineT GRACE … on
General Lung/Thoracic Cancer
By Barbro Kristin… on